Clinical trials
Recruiting Phase 3 Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abdul Bari | 1 |
| Alnylam Pharmaceuticals | 1 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Hanlim Pharm. Co., Ltd. | 1 |
| JW Pharmaceutical | 1 |
| Loma Linda University | 1 |
| Mayo Clinic | 1 |
| Suez Canal University | 1 |
| THPharm Corp. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 11 |
| Diabetes Mellitus, Type 2 | 3 |
| Cardiovascular Diseases | 2 |
| Hypertension, Pregnancy-Induced | 2 |
| Aortic Coarctation | 1 |
| Cataract | 1 |
| Dyslipidemias | 1 |
| Pre-Eclampsia | 1 |
| Renal Insufficiency, Chronic | 1 |
| Toxemia | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.